Citigroup’s Zentalis Pharmaceuticals ZNTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $22.6K | Sell |
19,447
-21,199
| -52% | -$24.6K | ﹤0.01% | 4315 |
|
|
2025
Q1 | $64.6K | Sell |
40,646
-4,855
| -11% | -$7.72K | ﹤0.01% | 4035 |
|
|
2024
Q4 | $138K | Buy |
45,501
+1,815
| +4% | +$5.5K | ﹤0.01% | 3826 |
|
|
2024
Q3 | $161K | Sell |
43,686
-240
| -0.5% | -$883 | ﹤0.01% | 3731 |
|
|
2024
Q2 | $180K | Sell |
43,926
-213,161
| -83% | -$872K | ﹤0.01% | 3225 |
|
|
2024
Q1 | $4.05M | Buy |
257,087
+111,169
| +76% | +$1.75M | ﹤0.01% | 1370 |
|
|
2023
Q4 | $2.21M | Buy |
145,918
+60,713
| +71% | +$920K | ﹤0.01% | 1575 |
|
|
2023
Q3 | $1.71M | Sell |
85,205
-202
| -0.2% | -$4.05K | ﹤0.01% | 1563 |
|
|
2023
Q2 | $2.41M | Sell |
85,407
-103,312
| -55% | -$2.91M | ﹤0.01% | 1538 |
|
|
2023
Q1 | $3.25M | Buy |
188,719
+86,785
| +85% | +$1.49M | ﹤0.01% | 1298 |
|
|
2022
Q4 | $2.05M | Sell |
101,934
-66,881
| -40% | -$1.35M | ﹤0.01% | 1504 |
|
|
2022
Q3 | $3.66M | Buy |
168,815
+37,965
| +29% | +$822K | ﹤0.01% | 1254 |
|
|
2022
Q2 | $3.68M | Buy |
130,850
+99,406
| +316% | +$2.79M | ﹤0.01% | 1259 |
|
|
2022
Q1 | $1.45M | Sell |
31,444
-30,220
| -49% | -$1.39M | ﹤0.01% | 2027 |
|
|
2021
Q4 | $5.18M | Buy |
61,664
+27,830
| +82% | +$2.34M | ﹤0.01% | 1265 |
|
|
2021
Q3 | $2.26M | Sell |
33,834
-42,731
| -56% | -$2.85M | ﹤0.01% | 1826 |
|
|
2021
Q2 | $4.07M | Sell |
76,565
-5,807
| -7% | -$309K | ﹤0.01% | 1578 |
|
|
2021
Q1 | $3.57M | Buy |
82,372
+70,352
| +585% | +$3.05M | ﹤0.01% | 1574 |
|
|
2020
Q4 | $625K | Buy |
12,020
+11,455
| +2,027% | +$596K | ﹤0.01% | 2491 |
|
|
2020
Q3 | $18K | Sell |
565
-841
| -60% | -$26.8K | ﹤0.01% | 4026 |
|
|
2020
Q2 | $68K | Buy |
+1,406
| New | +$68K | ﹤0.01% | 3644 |
|